DEVELOPMENT OF A NEW MAMMALIAN CELL EXPRESSION SYSTEM

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$500,000.00
Award Year:
1991
Program:
SBIR
Phase:
Phase II
Contract:
n/a
Agency Tracking Number:
11257
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Medimmune Inc.
35 W Watkins Mill Rd, Gaithersburg, MD, 20878
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
NUMEROUS EXPRESSION SYSTEMS EXIST FOR THE PRODUCTION OF PROTEINS IN BOTH PROKARYOTIC AND EUKARYOTIC CELLS. EACH SYSTEM HAS ITS OWN SET OF ADVANTAGES AS WELL AS SHORTCOMINGS. THE NEED REMAINS FOR A MAMMALIAN CELL EXPRESSION SYSTEM THAT CAN ACHIEVE HIGH-LEVEL TARGET GENE EXPRESSION, CORRECTLY PROCESS PROTEINS OF MAMMALIAN ORIGIN, AND IS ECONOMICAL AND EASY TO USE. RECENTLY, MOLECULAR VACCINES, INC., ESTABLISHED A MAMMALIAN EXPRESSION SYSTEM CAPABLE OF SIGNIFICANT PRODUCTION LEVELS OF TARGET PROTEINS. THIS SYSTEM IS BASED ON CO-INFECTION OF CULTURED CELLS WITH TWO RECOMBINANT VACCINIA VIRUSES. ONE RECOMBINANT VACCINIA VIRUS PROVIDES CONSTITUTIVE EXPRESSION OF BACTERIOPHAGE T7 RNA POLYMERASE, AND THE SECOND CONTAINS A T7-PROMOTER-CONTROLLED TARGET GENE. THE TWO-VIRUS SYSTEM WAS REQUIRED FOR STABILITY. IT IS PLANNED TO USE THE REGULATORY ELEMENTS OF THE ESCHERICHIA COLI LAC OPERATOR/REPRESSOR SYSTEM TO REGULATE EXPRESSION OF T7 RNA POLYMERASE. IF EXPRESSION OF T7 RNA POLYMERASE CAN BE CONTROLLED, A SINGLE-VIRUS EXPRESSION SYSTEM MAY BE FEASIBLE. IF SUCCESSFUL, THIS SYSTEM WILL BE EXPLOITED AS A SUPERIOR MEANS FOR THE EFFICIENT BIOPRODUCTION OF MAMMALIAN PROTEINS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government